BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9150392)

  • 1. Tolerance of high levels of wild-type p53 in transformed epithelial cells dependent on auto-regulation by mdm-2.
    Blaydes JP; Gire V; Rowson JM; Wynford-Thomas D
    Oncogene; 1997 Apr; 14(15):1859-68. PubMed ID: 9150392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased mdm-2 expression in a p53-independent manner blocks UV-induced cell cycle arrest and apoptosis in human osteosarcoma cells.
    Dong YB; Yang HL; Elliott MJ; McMasters KM
    Tumour Biol; 2003; 24(3):130-9. PubMed ID: 14610316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of transcription functions of the p53 tumor suppressor by the mdm-2 oncogene.
    Chen J; Lin J; Levine AJ
    Mol Med; 1995 Jan; 1(2):142-52. PubMed ID: 8529093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of Myc-dependent apoptosis by p53, c-Jun N-terminal kinases/stress-activated protein kinases, and Mdm-2.
    Yu K; Ravera CP; Chen YN; McMahon G
    Cell Growth Differ; 1997 Jul; 8(7):731-42. PubMed ID: 9218867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the proportion of p53 bound to mdm-2 in cells with defined growth characteristics.
    Momand J; Zambetti GP
    Oncogene; 1996 Jun; 12(11):2279-89. PubMed ID: 8649767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wild-type p53 protein is unable to activate the mdm-2 gene during F9 cell differentiation.
    Mayo LD; Berberich SJ
    Oncogene; 1996 Dec; 13(11):2315-21. PubMed ID: 8957072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The p53-mdm-2 autoregulatory feedback loop.
    Wu X; Bayle JH; Olson D; Levine AJ
    Genes Dev; 1993 Jul; 7(7A):1126-32. PubMed ID: 8319905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the C' terminus of murine p53 in the p53/mdm-2 regulatory loop.
    Almog N; Milyavsky M; Stambolsky P; Falcovitz A; Goldfinger N; Rotter V
    Carcinogenesis; 2001 May; 22(5):779-85. PubMed ID: 11323398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth.
    Finlay CA
    Mol Cell Biol; 1993 Jan; 13(1):301-6. PubMed ID: 8417333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mdm-2 gene is induced in response to UV light in a p53-dependent manner.
    Perry ME; Piette J; Zawadzki JA; Harvey D; Levine AJ
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11623-7. PubMed ID: 8265599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific p53-DNA complexes contain an mdm2-related protein.
    Hall AR; Milner J
    Oncogene; 1997 Mar; 14(11):1371-6. PubMed ID: 9178897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
    Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of p53 transcriptional activity by 1,10-phenanthroline, a metal chelator and redox sensitive compound.
    Sun Y; Bian J; Wang Y; Jacobs C
    Oncogene; 1997 Jan; 14(4):385-93. PubMed ID: 9053835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MDM-2 oncoprotein overexpression in laryngeal squamous cell carcinoma: association with wild-type p53 accumulation.
    Pruneri G; Pignataro L; Carboni N; Luminari S; Capaccio P; Neri A; Buffa R
    Mod Pathol; 1997 Aug; 10(8):785-92. PubMed ID: 9267820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mdm-2 expression correlates with wild-type p53 status in esophageal adenocarcinoma.
    Soslow RA; Altorki NK; Yang G; Xie D; Yang CS
    Mod Pathol; 1999 Jun; 12(6):580-6. PubMed ID: 10392633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutant p53-induced immortalization of primary human mammary epithelial cells.
    Gao Q; Hauser SH; Liu XL; Wazer DE; Madoc-Jones H; Band V
    Cancer Res; 1996 Jul; 56(13):3129-33. PubMed ID: 8674072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The high levels of p53 present in adenovirus early region 1-transformed human cells do not cause up-regulation of MDM2 expression.
    Grand RJ; Lecane PS; Owen D; Grant ML; Roberts S; Levine AJ; Gallimore PH
    Virology; 1995 Jul; 210(2):323-34. PubMed ID: 7618270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.
    Momand J; Zambetti GP; Olson DC; George D; Levine AJ
    Cell; 1992 Jun; 69(7):1237-45. PubMed ID: 1535557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of mdm-2 expression in Meth A tumor cells tolerating wild-type p53.
    Otto A; Deppert W
    Oncogene; 1993 Sep; 8(9):2591-603. PubMed ID: 8361769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of p53 transactivation through high-affinity binding sites.
    Chumakov AM; Miller CW; Chen DL; Koeffler HP
    Oncogene; 1993 Nov; 8(11):3005-11. PubMed ID: 8414502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.